Insmed Incorporated Insmed Incorporated

Insmed Incorporated

INSM

Hisse Senetlerindeki Sıralama #1117
Insmed Incorporated operates as a biopharmaceutical enterprise focused on... Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.
Hisse Fiyatı
$95.24
Piyasa Değeri
$20.80B
Değişim (1 gün)
-0.06%
Değişim (1 yıl)
-43.28%
Ülke
US
Ticaret Insmed Incorporated (INSM)

Kategori

Healthcare
Insmed Incorporated (INSM) için hisse bölünme geçmişi
Insmed Incorporated hissesi (sembol: INSM) toplamda 2 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Mar 03, 2011 tarihinde gerçekleşmiştir.
Jul 31, 2000 tarihinden önce alınan bir INSM hissesi bugün 0.025 INSM hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
2011-03-03 1:10 x0.1 x0.025
2000-07-31 1:4 x0.25 x0.25
Benzer şirketler veya rakipler için hisse bölünmeleri
Şirket Hisse bölünme sayısı Kümülatif Çarpan Ülke
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL